Stocks and Investing Stocks and Investing
Fri, January 27, 2023
Thu, January 26, 2023

Jayson Bedford Maintained (ABT) at Buy with Increased Target to $123 on, Jan 26th, 2023


Published on 2024-10-28 01:08:23 - WOPRAI, Jayson Bedford
  Print publication without navigation


Jayson Bedford of Raymond James, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $109 to $123 on, Jan 26th, 2023.

Jayson has made no other calls on ABT in the last 4 months.



There are 13 other peers that have a rating on ABT. Out of the 13 peers that are also analyzing ABT, 2 agree with Jayson's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Anthony Petrone of "Mizuho" Maintained at Hold with Increased Target to $110 on, Tuesday, January 24th, 2023
  • Matthew Taylor of "Jefferies" Initiated at Hold and Held Target at $110 on, Wednesday, October 12th, 2022


These are the ratings of the 11 analyists that currently disagree with Jayson


  • Mike Polark of "Wolfe Research" Maintained at Sell with Increased Target to $107 on, Wednesday, January 25th, 2023
  • Cecilia Furlong of "Morgan Stanley" Maintained at Buy with Increased Target to $133 on, Friday, January 6th, 2023
  • Matt Miksic of "Barclays" Maintained at Buy with Increased Target to $122 on, Wednesday, January 4th, 2023
  • Joshua Jennings of "TD Cowen" Maintained at Buy and Held Target at $130 on, Tuesday, December 13th, 2022
  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Increased Target to $125 on, Monday, December 12th, 2022
  • Shagun Singh of "RBC Capital" Maintained at Buy with Decreased Target to $126 on, Thursday, October 20th, 2022
  • Joanna Wiensch of "Citigroup" Maintained at Strong Buy with Decreased Target to $114 on, Thursday, October 20th, 2022
  • Robbie Marcus of "JP Morgan" Maintained at Buy with Decreased Target to $118 on, Thursday, October 20th, 2022
  • Vijay Kumar of "Evercore ISI Group" Maintained at Buy with Decreased Target to $110 on, Wednesday, October 19th, 2022
  • Ryan Zimmerman of "BTIG" Maintained at Strong Buy with Decreased Target to $123 on, Monday, October 17th, 2022
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Decreased Target to $140 on, Monday, October 10th, 2022
Contributing Sources